Gräserpollen (V01AA02)

TENDER DESCRIPTION

The Kaufmännische Krankenkasse - KKH (hereinafter referred to as KKH) pursues the aim of concluding discount contracts pursuant to Section 130a(8) of SGB V with all suitable pharmaceutical companies for the active ingredient stated under BT-21-Lot (ATC) and, where applicable, restrictively for certain dosage forms, within the scope of a so-called "Open-House procedure". Subject to uniform contract terms and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the conclusion of, or accession to, a discount contract pursuant to Section 130a(8) of SGB V for the aforementioned active ingredient. Interested pharmaceutical companies may request the participation documents and the contract using the contact address stated. The prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits the requested participation documents fully completed and signed. A contract will be concluded with each pharmaceutical company that meets the participation requirements. Exclusivity is not provided. Accession and/or contract conclusion may be carried out at any time and on the same…

TENDER BRIEF

TENDER DOCUMENTS